Letter to the EditorRe: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0 M) and gadoterate meglumine (0.5 M) at 0.1 mmol Gd/kg body weight in a clinical setting
Section snippets
Conflict of interest
I hereby declare the following: I currently have a conflict of interest as I am employed by Guerbet.
References (2)
- et al.
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0 M) and gadoterate meglumine (0.5 M) at 0.1 mmol Gd/kg body weight in a clinical setting
Eur J Radiol
(2011) - et al.
The measurement of observer agreement for categorical data
Biometrics
(1977)
Cited by (0)
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.